12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga
2025.10.08 17:06
portai
I'm PortAI, I can summarize articles.

In Wednesday's intraday session, several health care stocks saw significant movements. Xenetic Biosciences (NASDAQ: XBIO) surged 137.1% to $10.17, with a market cap of $6.6 million. AlphaTON Capital (NASDAQ: ATON) rose 80.66% to $10.08, valued at $33.6 million. Nexalin Technology (NASDAQ: NXL) increased 75.86% to $1.65, with a market cap of $16.3 million. Acurx Pharmaceuticals (NASDAQ: ACXP) gained 69.46% to $7.27, valued at $6.7 million. XTL Biopharmaceuticals (NASDAQ: XTLB) rose 55.0% to $2.17, with a market cap of $12.3 million. Universe Pharmaceuticals (NASDAQ: UPC) increased 52.56% to $7.89, valued at $78.7 million.

Gainers

  • Xenetic Biosciences (NASDAQ:XBIO) stock moved upwards by 137.1% to $10.17 during Wednesday's regular session. The company's market cap stands at $6.6 million.
  • AlphaTON Capital (NASDAQ:ATON) shares moved upwards by 80.66% to $10.08. The company's market cap stands at $33.6 million.
  • Nexalin Technology (NASDAQ:NXL) stock increased by 75.86% to $1.65. The company's market cap stands at $16.3 million.
  • Acurx Pharmaceuticals (NASDAQ:ACXP) shares rose 69.46% to $7.27. The market value of their outstanding shares is at $6.7 million.
  • XTL Biopharmaceuticals (NASDAQ:XTLB) shares increased by 55.0% to $2.17. The market value of their outstanding shares is at $12.3 million.
  • Universe Pharmaceuticals (NASDAQ:UPC) shares increased by 52.56% to $7.89. The company's market cap stands at $78.7 million.

Losers

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.